SAMSUNG PHARM. Co., LTD. (001360.KS)
KRW 1603.0
(0.25%)
KRW 1603.0
(0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.65 Billion | -1.91 Billion | -7.16 Billion | -2.55 Billion | -2.43 Billion | -6.52 Billion |
| Net Income | -24.81 Billion | -25.09 Billion | -40.27 Billion | -39.87 Billion | 6.88 Billion | -2.07 Billion |
| Depreciation & Amortization | 1.91 Billion | 3 Billion | 3.2 Billion | 4.19 Billion | 4.21 Billion | 3.76 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -16.05 Billion | 1.56 Billion | -212.87 Million | -2.58 Billion | -3.92 Billion | -6.82 Billion |
| Other non-cash items | 11.29 Billion | 18.6 Billion | 30.12 Billion | 35.7 Billion | -9.6 Billion | -1.38 Billion |
| Investing Cash Flow | -2.63 Billion | 12.82 Billion | 18.98 Billion | -6.61 Billion | 8.64 Billion | -6.59 Billion |
| Investments in PPE | -12.77 Billion | -3.03 Billion | -4.06 Billion | -7.15 Billion | -13.88 Billion | -3.69 Billion |
| Acquisitions | 7.45 Million | - | 58.9 Billion | 1 Billion | 7.37 Billion | 1.07 Billion |
| Investment purchases | -31.87 Billion | -70.89 Billion | -67.02 Billion | -11.91 Billion | -4.81 Billion | -15 Billion |
| Sales/Maturities of investments | 42 Billion | 52.6 Billion | 19.89 Billion | 10.79 Billion | 18.1 Billion | 4.9 Billion |
| Other Investing Activities | 7.33 Million | 34.15 Billion | 11.26 Billion | 664.16 Million | 1.86 Billion | 6.11 Billion |
| Financing Cash Flow | -1.42 Billion | -1 Billion | -12.21 Billion | 30.63 Billion | -4.31 Billion | 13.33 Billion |
| Debt repayment | -318.36 Million | - | -11.66 Billion | -5.6 Billion | -4.09 Billion | -17.89 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 9.98 Billion | - | 31.23 Billion |
| Other Financing Activities | -1.1 Billion | - | -543.91 Million | 26.25 Billion | -225.38 Million | - |
| Accounts receivables | 441.35 Million | 2.78 Billion | 3.81 Billion | 421.62 Million | -1.39 Billion | -1.97 Billion |
| Accounts payables | 1.13 Billion | -569.25 Million | -277.55 Million | -291.29 Million | 2.24 Billion | -1.53 Billion |
| Inventory | -14.43 Billion | -1.72 Billion | -4.12 Billion | -4 Billion | -3.6 Billion | 802.17 Million |
| Other working capital | -3.19 Billion | 1.06 Billion | 368.69 Million | 1.29 Billion | -1.17 Billion | -7.62 Billion |
| Cash at beginning of period | 35.98 Billion | 26.09 Billion | 26.44 Billion | 5.04 Billion | 3.15 Billion | 2.93 Billion |
| Cash at end of period | 4.28 Billion | 35.98 Billion | 26.09 Billion | 26.44 Billion | 5.04 Billion | 3.15 Billion |
| Capital Expenditure | -12.77 Billion | -3.03 Billion | -4.06 Billion | -7.15 Billion | -13.88 Billion | -3.69 Billion |
| Effect of forex changes on cash | 11.81 Million | -16.54 Million | 41.72 Million | -71.11 Million | 10.00 | -10.00 |
| Net cash flow / Change in cash | -31.7 Billion | 9.88 Billion | -347.39 Million | 21.39 Billion | 1.89 Billion | 219.73 Million |
| Free Cash Flow | -40.43 Billion | -4.94 Billion | -11.22 Billion | -9.7 Billion | -16.31 Billion | -10.21 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.27 Billion | -4.8 Billion | -12.16 Billion | -24.81 Billion | -6.24 Billion | -3.6 Billion |
| Depreciation & Amortization | 453.95 Million | 450.94 Million | 495.27 Million | 1.91 Billion | 497.61 Million | 475.33 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.77 Billion | -541.46 Million | -3.5 Billion | -16.05 Billion | -2.9 Billion | -7.32 Billion |
| Other non-cash items | 6.06 Billion | 3.65 Billion | 8.24 Billion | 11.29 Billion | 2.24 Billion | 1.66 Billion |
| Investing Cash Flow | -9.78 Billion | -5.38 Billion | 9.54 Billion | -2.63 Billion | -2.66 Billion | -7.01 Billion |
| Investments in PPE | -5.00 | -27.99 Million | 154.63 Million | -12.77 Billion | -400.08 Million | -12.19 Billion |
| Acquisitions | - | 24.5 Million | 7.45 Million | 7.45 Million | 49.07 Million | -30 Billion |
| Investment purchases | -2.41 Billion | -5.35 Billion | -11.87 Billion | -31.87 Billion | -4.29 Billion | -24.78 Billion |
| Sales/Maturities of investments | - | - | -1.26 Billion | 42 Billion | 2 Billion | 30 Billion |
| Other Investing Activities | -7.37 Billion | -20.99 Million | 22.53 Billion | 7.33 Million | -9.57 Million | 29.95 Billion |
| Financing Cash Flow | -243.16 Million | 43.41 Billion | -202.98 Million | -1.42 Billion | -276.37 Million | -301.55 Million |
| Debt repayment | - | -4 Billion | - | -318.36 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 39.66 Billion | - | - | - | - |
| Other Financing Activities | -243.16 Million | 10.00 | - | -1.1 Billion | - | - |
| Accounts receivables | 275.14 Million | 680.67 Million | -220.65 Million | 441.35 Million | 1.53 Billion | -1.43 Billion |
| Accounts payables | -775.01 Million | -410.57 Million | 615.45 Million | 1.13 Billion | -1.3 Billion | 45.67 Million |
| Inventory | -594.81 Million | -819.45 Million | -2.98 Billion | -14.43 Billion | -2.95 Billion | -3.4 Billion |
| Other working capital | -683.22 Million | 7.89 Million | -914.01 Million | -3.19 Billion | -184.67 Million | -2.53 Billion |
| Cash at beginning of period | 39.63 Billion | 4.28 Billion | 1.88 Billion | 35.98 Billion | 11.21 Billion | 27.3 Billion |
| Cash at end of period | 22.07 Billion | 39.63 Billion | 4.28 Billion | 4.28 Billion | 1.88 Billion | 11.21 Billion |
| Capital Expenditure | -5.00 | -27.99 Million | 154.63 Million | -12.77 Billion | -400.08 Million | -12.19 Billion |
| Effect of forex changes on cash | - | 15.88 Million | -22.42 Million | 11.81 Million | 13.46 Million | 4.46 Million |
| Net cash flow / Change in cash | -17.55 Billion | 35.35 Billion | 2.39 Billion | -31.7 Billion | -9.33 Billion | -16.09 Billion |
| Free Cash Flow | -7.54 Billion | -2.72 Billion | -6.76 Billion | -40.43 Billion | -6.8 Billion | -20.97 Billion |
300457
RWC
SEQI
2379
0592
VBNK